Navigation Links
Gentiva Reports Fourth Quarter and Fiscal 2008 Results
Date:2/18/2009

Company Raises 2009 Performance Outlook

MELVILLE, N.Y., Feb. 18 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), a leading provider of comprehensive home health services, today reported fourth quarter results, led by 20% revenue growth and 39% operating contribution growth from its Home Health segment, as the Company continued to execute on its strategy of delivering clinical innovation and quality care to patients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060323/NYTH117LOGO )

Performance highlights for the quarter ended December 28, 2008 included the following Company results compared to the fourth quarter ended December 30, 2007:

  • Net revenues of $282.9 million compared to $313.4 million, which included net revenues of $76.3 million from its CareCentrix business unit in the 2007 fourth quarter. Excluding prior-year net revenues from CareCentrix, Gentiva's net revenues grew $45.8 million, or 19% in the 2008 fourth quarter. The Company sold a majority interest in CareCentrix to Water Street Healthcare Partners on September 25, 2008.

  • Net income of $12.8 million, or $0.43 per diluted share, compared to net income of $8.8 million or $0.31 per diluted share in the 2007 fourth quarter. Adjusted net income, which excludes special charges related to restructuring and integration activities, was $0.44 per diluted share in the 2008 period compared to $0.31 per diluted share in the prior-year period.

  • A 19% increase in earnings before interest, taxes, depreciation and amortization (EBITDA) to $30.0 million in the fourth quarter of 2008; EBITDA as a percentage of
    '/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... 8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... financial results for the second quarter of fiscal ... "After rigorous evaluation of numerous global in-licensing opportunities, ... Melbourne -based drug development company, into YM ... , Chairman & CEO of YM BioSciences Inc. ...
(Date:2/8/2010)... , Feb. 8 Biocell ... with maternal-fetal-medicine doctors by attending the Society for ... has been working with perinatologists and Ob/Gyn doctors ... , CEO of Biocell Center Corporation. "We understand ... mothers and families and we are hoping to ...
(Date:2/8/2010)... to present the critical processes that comprise a more accurate ... ... Chicago, IL (PRWEB) February 8, 2010 ... software, today announced that both Kristin Lucas and Kelly Larrabee, ... at the CBI Forecasting & Budgeting conference at the Marriott ...
(Date:2/8/2010)... announce that it has hired Lisa Wichman and Sahar Meyer to its ... an Account Manager and will focus on key healthcare markets in the ... that group Omaha, NE. , ... Foothill Ranch, CA (Vocus) February 8, ... the hiring of a new Account Manager and Manager of Analytics. , ...
Breaking Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 3
... and MTAX: CTIC) management to hold a conference call ... update on Zevalin asset,purchase, CMS reimbursement, and PIX301 timing ... December 27 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 ... at http://www.cticseattle.com - webcast will ...
... RICHMOND, Va., Dec. 26 Insmed Inc. (Nasdaq:,INSM), ... that it has requested a hearing before a ... Determination to delist the,Company,s common stock from the ... from the Nasdaq Stock Market ("Nasdaq") on,December 20, ...
... CEO -, DALLAS, Dec. 26 Access Pharmaceuticals, ... Jeffrey B.,Davis has been appointed to the additional role ... CEO of the Company for health reasons. Mr.,Seiler has ... believe that Access has an exciting future with ProLindac(TM),MuGard(TM), ...
Other Biology Technology:Insmed to Appeal Delisting Notification From Nasdaq 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 3
(Date:2/8/2010)... to a significantly elevated risk of having a child ... an exhaustive study of all births in California during ... paternal age is associated with elevated autism risk only ... under 30, the study found. , Published online today ... Research, the study, "Independent and Dependent Contributions of ...
(Date:2/7/2010)... (NCI) have found that the prevalence of tamoxifen use ... a personal history of breast cancer is very low. ... breast cancer in women who are at increased risk ... published in the February issue of Cancer Epidemiology, ... Association for Cancer Research. , The low prevalence ...
(Date:2/7/2010)... Consuming two or more soft drinks per week increased ... compared to individuals who did not consume soft drinks, ... & Prevention , a journal of the American Association ... cancer remains one of the most deadly, and only ... five years later. , Mark Pereira, Ph.D., senior author ...
Breaking Biology News(10 mins):UC Davis study confirms link between advanced maternal age and autism 2UC Davis study confirms link between advanced maternal age and autism 3UC Davis study confirms link between advanced maternal age and autism 4Few women take tamoxifen to prevent breast cancer 2Soft drink consumption may increase risk of pancreatic cancer 2Perfect Fathers Day Gift 3A The Sound of Silence 47810 1Perfect Fathers Day Gift 3A The Sound of Silence 47810 2Perfect Fathers Day Gift 3A The Sound of Silence 47810 3Two Drugs Better Than One for Crohns Patients 47809 1Two Drugs Better Than One for Crohns Patients 47809 2Two Drugs Better Than One for Crohns Patients 47809 3Pay for Performance Doesnt Shortchange Patients 47807 1Pay for Performance Doesnt Shortchange Patients 47807 2Pay for Performance Doesnt Shortchange Patients 47807 3
... research has shown that reduced calorie intake can increase ... and his collaborators* have discovered that reducing calorie intake ... health and longevity benefits of life-long calorie reduction. Importantly, ... using this knowledge to establish a novel screening technique ...
... according to scientific gospel, social behavior is dictated primarily ... reproduction. , That may well be true for many ... the University of Wisconsin-Madison have found evidence that social ... be with one another. What's more, the researchers say, ...
... a unique protein from jellyfish that could be inserted ... cause them to radiate a brilliant green color. This ... many new discoveries regarding how living cells function. But ... detection: plants harbor tough cell walls and enormous ...
Other Biology News:It's never too late to get it back! Aging interrupted 2In young mice, gregariousness seems to reside in the genes 2In young mice, gregariousness seems to reside in the genes 3
Rabbit polyclonal to Kallikrein 1 ( Abpromise for all tested applications). Antigen: Full length native kallikrein from tissue (Human) Entrez Gene ID: 3816 Swiss Protein ID: P06870...
Biotin d anti-mouse Tim-1...
... protein. The epitope is specific for ... any other known protein.,SPECIES REACTIVITIES: ... rabbit, bovine, porcine and guinea pig. ... and mouse (17/19 residues) and chick ...
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
Biology Products: